arrow_back Back to App

Overdose Prevention Support: Fentanyl and Xylazine Test Strips Funding.

This new act aims to broaden the use of federal funds for addiction prevention programs. It allows these funds to be used for purchasing and distributing fentanyl and xylazine test strips, which is intended to help prevent overdoses. Citizens and communities will gain better access to tools that reduce risks associated with substance use.
Key points
The act authorizes federal grants to be used for fentanyl and xylazine test strips.
This aims to strengthen overdose prevention and substance use disorder activities.
Increases access to safety tools for individuals at risk of substance use.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4106
Sponsor: Rep. Crockett, Jasmine [D-TX-30]
Process start date: 2023-06-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Test Strip Access Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4106.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-14.

What are the main provisions?

Key points include:

  • The act authorizes federal grants to be used for fentanyl and xylazine test strips.
  • This aims to strengthen overdose prevention and substance use disorder activities.
  • Increases access to safety tools for individuals at risk of substance use.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Crockett, Jasmine [D-TX-30].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health